IL17A and neoplasm: Differences were also seen in the cytokine production profile from both tumor cells themselves (Fig. 5C) or in serum exosomes of tumor‐bearing mice (Fig. 5D), with enhanced IL‐6 and IL‐17, and moderately decreased TNFα in 4THM versus EMT6 tumor bearers.